ACAD
Price
$21.98
Change
+$0.64 (+3.00%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
3.57B
54 days until earnings call
AURA
Price
$6.50
Change
+$0.41 (+6.72%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
403.03M
62 days until earnings call
Interact to see
Advertisement

ACAD vs AURA

Header iconACAD vs AURA Comparison
Open Charts ACAD vs AURABanner chart's image
ACADIA Pharmaceuticals
Price$21.98
Change+$0.64 (+3.00%)
Volume$32.33K
Capitalization3.57B
Aura Biosciences
Price$6.50
Change+$0.41 (+6.72%)
Volume$1.74K
Capitalization403.03M
ACAD vs AURA Comparison Chart
Loading...
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACAD vs. AURA commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a Hold and AURA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (ACAD: $21.33 vs. AURA: $6.11)
Brand notoriety: ACAD and AURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 70% vs. AURA: 76%
Market capitalization -- ACAD: $3.57B vs. AURA: $403.03M
ACAD [@Biotechnology] is valued at $3.57B. AURA’s [@Biotechnology] market capitalization is $403.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 1 FA rating(s) are green whileAURA’s FA Score has 0 green FA rating(s).

  • ACAD’s FA Score: 1 green, 4 red.
  • AURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ACAD is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 5 TA indicator(s) are bullish while AURA’s TA Score has 7 bullish TA indicator(s).

  • ACAD’s TA Score: 5 bullish, 6 bearish.
  • AURA’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, AURA is a better buy in the short-term than ACAD.

Price Growth

ACAD (@Biotechnology) experienced а -4.31% price change this week, while AURA (@Biotechnology) price change was +0.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.92%. For the same industry, the average monthly price growth was +17.56%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

ACAD is expected to report earnings on Jul 30, 2025.

AURA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+11.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACAD($3.57B) has a higher market cap than AURA($403M). ACAD YTD gains are higher at: 16.240 vs. AURA (-25.730). ACAD has higher annual earnings (EBITDA): 102M vs. AURA (-91.84M). ACAD has more cash in the bank: 682M vs. AURA (174M). AURA has less debt than ACAD: AURA (19.1M) vs ACAD (56M). ACAD has higher revenues than AURA: ACAD (996M) vs AURA (0).
ACADAURAACAD / AURA
Capitalization3.57B403M886%
EBITDA102M-91.84M-111%
Gain YTD16.240-25.730-63%
P/E Ratio16.04N/A-
Revenue996M0-
Total Cash682M174M392%
Total Debt56M19.1M293%
FUNDAMENTALS RATINGS
ACAD: Fundamental Ratings
ACAD
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
27
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACADAURA
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 11 days ago
73%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMUEX13.29N/A
N/A
GMO US Equity III
SWSCX18.41N/A
N/A
Schwab Small-Cap Equity
CLTAX15.50N/A
N/A
Catalyst/Lyons Tactical Allocation A
ACIIX8.55N/A
N/A
American Century Equity Income I
MRBPX23.78N/A
N/A
BlackRock Balanced R

ACAD and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACAD has been loosely correlated with INZY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ACAD jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACAD
1D Price
Change %
ACAD100%
-2.02%
INZY - ACAD
50%
Loosely correlated
+0.25%
AURA - ACAD
45%
Loosely correlated
-0.57%
CRSP - ACAD
42%
Loosely correlated
+1.37%
PRME - ACAD
41%
Loosely correlated
+3.79%
PGEN - ACAD
40%
Loosely correlated
N/A
More

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with MGTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-0.57%
MGTX - AURA
50%
Loosely correlated
+0.55%
VRDN - AURA
49%
Loosely correlated
+0.60%
BEAM - AURA
48%
Loosely correlated
-0.87%
ABOS - AURA
47%
Loosely correlated
-0.47%
CCCC - AURA
47%
Loosely correlated
-4.87%
More